Daxor Corporation (DXR)

NASDAQ: DXR · IEX Real-Time Price · USD
9.61
-0.06 (-0.58%)
Apr 17, 2024, 11:25 AM EDT - Market open
-0.58%
Market Cap 45.31M
Revenue (ttm) 34.31M
Net Income (ttm) 5.75M
Shares Out 4.73M
EPS (ttm) 1.41
PE Ratio 6.77
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 840
Open 9.49
Previous Close 9.67
Day's Range 9.49 - 9.61
52-Week Range 7.11 - 13.13
Beta -0.44
Analysts n/a
Price Target n/a
Earnings Date n/a

About DXR

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 a... [Read more]

Sector Healthcare
Founded 1970
Employees 37
Stock Exchange NASDAQ
Ticker Symbol DXR
Full Company Profile

Financial Performance

In 2023, Daxor's revenue was $34.59 million, an increase of 448.16% compared to the previous year's $6.31 million. Earnings were $280,640, a decrease of -94.58%.

Financial Statements

News

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

450-Bed Hospital Purchases BVA-100 ™ Blood Volume Analyzer to Launch H eart Failure P rogram

7 days ago - GlobeNewsWire

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, an...

23 days ago - GlobeNewsWire

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024

Oak Ridge, TN, March 22, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces an investor call to be held on Monday, March 25, ...

26 days ago - GlobeNewsWire

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders ...

4 weeks ago - GlobeNewsWire

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Strong Start to 2024 with Unaudited Revenue Climbing 229.1% in First Two Months of 2024 YoY Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in bloo...

4 weeks ago - GlobeNewsWire

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base

Oak Ridge, TN, March 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation  (Nasdaq: DXR), the global leader in blood volume measurement technology today announces the expansion of blood volume analysis (BVA...

5 weeks ago - GlobeNewsWire

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients

Only Daxor's BVA Diagnostic Was Shown to Accurately Reflect Blood Volume Compared to Inferior Surrogates Oak Ridge, TN, March 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global l...

5 weeks ago - GlobeNewsWire

Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference

Oak Ridge, TN, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the Technology and ...

7 weeks ago - GlobeNewsWire

Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions

Oak Ridge, TN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today announces two significant new customer transactions wit...

2 months ago - GlobeNewsWire

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside Oak Ridge, TN, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader i...

3 months ago - GlobeNewsWire

New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure Patients

Data From Study Funded by NIH Presented at the American Heart Association Annual Meeting Oak Ridge, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood vo...

5 months ago - GlobeNewsWire

Expert Panelists Advocate Use of Daxor's Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting

Leading Clinicians Highlight Significant Outcome Improvements with Daxor's Blood Volume Analysis Innovative Technology

6 months ago - GlobeNewsWire

New Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific Meeting

Blood Volume Analysis (BVA) in 83-Patient Study Provided Highly Effective Guidance for Care of Heart Failure Patients Otherwise Unavailable Using Common Proxy Diagnostic Methods

6 months ago - GlobeNewsWire

Daxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services Program

Support for Development of Daxor's Non-Nuclear Tracer for Next Generation Blood Volume Analyzer Systems Aims to Deliver Gold Standard Accuracy with Increased Access, Ease of Use, and Frequency of Test...

7 months ago - GlobeNewsWire

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023

Daxor's Blood Volume Technology Featured at Scientific Session Oak Ridge, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technolo...

7 months ago - GlobeNewsWire

Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients

Oak Ridge, TN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Daxor C orporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the National Institutes of Health (NI...

7 months ago - GlobeNewsWire

Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Oak Ridge, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh wi...

7 months ago - GlobeNewsWire

Daxor Corporation Reports a 20.64 Percent Increase in Diagnostic Test Kits Revenue From Prior Year Period in Form N-CSR Filing for the Six Months Ended June 30, 2023

Net Assets Increases to $30.4 Million From $29.0 Million Oak Ridge, TN, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, ann...

8 months ago - GlobeNewsWire

JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®

Researchers Call for Larger Clinical Trial Citing Outcomes from Study Oak Ridge, TN, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement te...

8 months ago - GlobeNewsWire

JACC-HF Study Compares Daxor's BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure Patients

Volume and Pressure Measures are Complementary, Not Interchangeable Oak Ridge, TN, July 12, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement tech...

10 months ago - GlobeNewsWire

Daxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzer

Oak Ridge, TN, July 05, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the United States Defense Health Agency...

10 months ago - GlobeNewsWire

Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering

Oak Ridge, TN, June 22, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that Maxim Group LLC (“Maxim”), as Represent...

10 months ago - GlobeNewsWire

Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference

Oak Ridge, TN, June 12, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that Michael Feldschuh, CEO and President ha...

11 months ago - GlobeNewsWire

Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering

Oak Ridge, TN, May 25, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the closing of it...

11 months ago - GlobeNewsWire

Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering

Oak Ridge, TN, May 22, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of it...

11 months ago - GlobeNewsWire